173 related articles for article (PubMed ID: 37628900)
21. In-vivo histamine H3 receptor antagonism activates cellular signaling suggestive of symptomatic and disease modifying efficacy in Alzheimer's disease.
Bitner RS; Markosyan S; Nikkel AL; Brioni JD
Neuropharmacology; 2011; 60(2-3):460-6. PubMed ID: 21044639
[TBL] [Abstract][Full Text] [Related]
22. Isorhynchophylline exerts antidepressant-like effects in mice
Xian YF; Ip SP; Li HQ; Qu C; Su ZR; Chen JN; Lin ZX
FASEB J; 2019 Sep; 33(9):10393-10408. PubMed ID: 31233346
[TBL] [Abstract][Full Text] [Related]
23. The histamine H3 receptor modulates dopamine D2 receptor-dependent signaling pathways and mouse behaviors.
Xu J; Pittenger C
J Biol Chem; 2023 Apr; 299(4):104583. PubMed ID: 36871761
[TBL] [Abstract][Full Text] [Related]
24. Histamine H3 receptor antagonist decreases cue-induced alcohol reinstatement in mice.
Nuutinen S; Mäki T; Rozov S; Bäckström P; Hyytiä P; Piepponen P; Panula P
Neuropharmacology; 2016 Jul; 106():156-63. PubMed ID: 26107118
[TBL] [Abstract][Full Text] [Related]
25. Semaglutide, a novel glucagon-like peptide-1 agonist, amends experimental autoimmune encephalomyelitis-induced multiple sclerosis in mice: Involvement of the PI3K/Akt/GSK-3β pathway.
Sadek MA; Kandil EA; El Sayed NS; Sayed HM; Rabie MA
Int Immunopharmacol; 2023 Feb; 115():109647. PubMed ID: 36584570
[TBL] [Abstract][Full Text] [Related]
26. [Ershiwuwei Shanhu Pills regulate Akt/mTOR/GSK-3β signaling pathway to alleviate Alzheimer's disease mice].
Luo XM; Zhang BY; Ding Y; Wang CP; Luo QL; Tan R; Gu J; Gong PY
Zhongguo Zhong Yao Za Zhi; 2022 Apr; 47(8):2074-2081. PubMed ID: 35531723
[TBL] [Abstract][Full Text] [Related]
27. The ethanolic extract of the Eclipta prostrata L. ameliorates the cognitive impairment in mice induced by scopolamine.
Jung WY; Kim H; Park HJ; Jeon SJ; Park HJ; Choi HJ; Kim NJ; Jang DS; Kim DH; Ryu JH
J Ethnopharmacol; 2016 Aug; 190():165-73. PubMed ID: 27267831
[TBL] [Abstract][Full Text] [Related]
28. Erinacine Facilitates the Opening of the Mitochondrial Permeability Transition Pore Through the Inhibition of the PI3K/ Akt/GSK-3β Signaling Pathway in Human Hepatocellular Carcinoma.
Zhou LJ; Mo YB; Bu X; Wang JJ; Bai J; Zhang JW; Cheng AB; Ma JH; Wang YW; Xie YX
Cell Physiol Biochem; 2018; 50(3):851-867. PubMed ID: 30355923
[TBL] [Abstract][Full Text] [Related]
29. The dual-active histamine H3 receptor antagonist and acetylcholine esterase inhibitor E100 ameliorates stereotyped repetitive behavior and neuroinflammmation in sodium valproate induced autism in mice.
Eissa N; Azimullah S; Jayaprakash P; Jayaraj RL; Reiner D; Ojha SK; Beiram R; Stark H; Łażewska D; Kieć-Kononowicz K; Sadek B
Chem Biol Interact; 2019 Oct; 312():108775. PubMed ID: 31369746
[TBL] [Abstract][Full Text] [Related]
30. Atorvastatin enhances neurite outgrowth in cortical neurons in vitro via up-regulating the Akt/mTOR and Akt/GSK-3β signaling pathways.
Jin Y; Sui HJ; Dong Y; Ding Q; Qu WH; Yu SX; Jin YX
Acta Pharmacol Sin; 2012 Jul; 33(7):861-72. PubMed ID: 22705730
[TBL] [Abstract][Full Text] [Related]
31. Ameliorative effect of nicergoline on cognitive function through the PI3K/AKT signaling pathway in mouse models of Alzheimer's disease.
Zang G; Fang L; Chen L; Wang C
Mol Med Rep; 2018 May; 17(5):7293-7300. PubMed ID: 29568940
[TBL] [Abstract][Full Text] [Related]
32. Chromium picolinate attenuates cognitive deficit in ICV-STZ rat paradigm of sporadic Alzheimer's-like dementia via targeting neuroinflammatory and IRS-1/PI3K/AKT/GSK-3β pathway.
Akhtar A; Dhaliwal J; Saroj P; Uniyal A; Bishnoi M; Sah SP
Inflammopharmacology; 2020 Apr; 28(2):385-400. PubMed ID: 31898080
[TBL] [Abstract][Full Text] [Related]
33. The Histamine H3 Receptor Differentially Modulates Mitogen-activated Protein Kinase (MAPK) and Akt Signaling in Striatonigral and Striatopallidal Neurons.
Rapanelli M; Frick LR; Horn KD; Schwarcz RC; Pogorelov V; Nairn AC; Pittenger C
J Biol Chem; 2016 Sep; 291(40):21042-21052. PubMed ID: 27510032
[TBL] [Abstract][Full Text] [Related]
34. The involvement of PI3K/Akt/mTOR/GSK3β signaling pathways in the antidepressant-like effect of AZD6765.
Neis VB; Moretti M; Rosa PB; Dalsenter YO; Werle I; Platt N; Kaufmann FN; Rosado AF; Besen MH; Rodrigues ALS
Pharmacol Biochem Behav; 2020 Nov; 198():173020. PubMed ID: 32861641
[TBL] [Abstract][Full Text] [Related]
35. Adenosine N1-Oxide Exerts Anti-inflammatory Effects through the PI3K/Akt/GSK-3β Signaling Pathway and Promotes Osteogenic and Adipocyte Differentiation.
Ohashi E; Kohno K; Arai N; Harashima A; Ariyasu T; Ushio S
Biol Pharm Bull; 2019; 42(6):968-976. PubMed ID: 31155593
[TBL] [Abstract][Full Text] [Related]
36. H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/ELK-1 pathway.
Francis H; Franchitto A; Ueno Y; Glaser S; DeMorrow S; Venter J; Gaudio E; Alvaro D; Fava G; Marzioni M; Vaculin B; Alpini G
Lab Invest; 2007 May; 87(5):473-87. PubMed ID: 17334413
[TBL] [Abstract][Full Text] [Related]
37. Studies on Anticonvulsant Effects of Novel Histamine H3R Antagonists in Electrically and Chemically Induced Seizures in Rats.
Alachkar A; Łażewska D; Latacz G; Frank A; Siwek A; Lubelska A; Honkisz-Orzechowska E; Handzlik J; Stark H; Kieć-Kononowicz K; Sadek B
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380674
[TBL] [Abstract][Full Text] [Related]
38. Stimulation of ACE2/ANG(1-7)/Mas Axis by Diminazene Ameliorates Alzheimer's Disease in the D-Galactose-Ovariectomized Rat Model: Role of PI3K/Akt Pathway.
Kamel AS; Abdelkader NF; Abd El-Rahman SS; Emara M; Zaki HF; Khattab MM
Mol Neurobiol; 2018 Oct; 55(10):8188-8202. PubMed ID: 29516284
[TBL] [Abstract][Full Text] [Related]
39. Effects of histamine H3 receptor ligands on the rewarding, stimulant and motor-impairing effects of ethanol in DBA/2J mice.
Nuutinen S; Vanhanen J; Pigni MC; Panula P
Neuropharmacology; 2011 Jun; 60(7-8):1193-9. PubMed ID: 21044640
[TBL] [Abstract][Full Text] [Related]
40. [Moxibustion at acpoints of governor vessel on regulating PI3K/Akt/mTOR signaling pathway and enhancing autophagy process in APP/PS1 double-transgenic Alzheimer's disease mice].
Zhang LD; Han W; Zhu CF; Song XG; Cheng H; Yang K; Qin XF; Zhang JY; Gui L
Zhongguo Zhen Jiu; 2019 Dec; 39(12):1313-8. PubMed ID: 31820607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
